NPPB and Patent ductus arteriosus: In an interventional study in preterm infants <33 weeks' gestation, indomethacin therapy was given if plasma NT-proBNP concentration was ≥10,180 pg/mL on the 2nd day of life, the cutoff for predicting HS-PDA.